NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial

Abstract Background We tested the hypothesis that, after initial improvement with intravenous ketamine in patients with bipolar disorder (BD) with severe depression and acute suicidal thinking or behavior, a fixed-dose combination of oral D-cycloserine (DCS) and lurasidone (NRX-101) can maintain imp...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Andrew Nierenberg, Philip Lavin, Daniel C. Javitt, Richard Shelton, Michael T. Sapko, Sanjay Mathew, Robert E. Besthof, Jonathan C. Javitt
Format:	Artigo
Jezik:	Inglês
Izdano:	SpringerOpen 2023-08-01
Serija:	International Journal of Bipolar Disorders
Teme:	Bipolar disorder Depression Suicidal ideation Ketamine Lurasidone Hydrochloride Cycloserine
Online dostop:	https://doi.org/10.1186/s40345-023-00308-5
Oznake:	Označite Brez oznak, prvi označite!